These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30324897)

  • 1. Pharmaco-Audiology Vigilance in the Treatment of Adult Patients with HIV/Aids: Ototoxicity Monitoring Protocol Recommendation.
    Khoza-Shangase K
    Infect Disord Drug Targets; 2020; 20(1):33-42. PubMed ID: 30324897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk versus Benefit: Who Assesses this in the Management of Patients on Ototoxic Drugs?
    Khoza-Shangase K
    J Pharm Bioallied Sci; 2017; 9(3):171-177. PubMed ID: 28979071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity: A review of South African studies.
    Moodley S; Storbeck C; Gama N
    S Afr Fam Pract (2004); 2021 Mar; 63(1):e1-e10. PubMed ID: 33764142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Are the Current Audiological Practices for Ototoxicity Assessment and Management in the South African Healthcare Context?
    Khoza-Shangase K; Masondo N
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
    Paken J; Govender CD; Sewram V
    BMC Womens Health; 2017 Dec; 17(1):129. PubMed ID: 29228931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity monitoring in South African cancer facilities: A national survey.
    Ehlert K; Heinze B; Swanepoel W
    S Afr J Commun Disord; 2022 Jan; 69(1):e1-e10. PubMed ID: 35144440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
    Garinis AC; Cornell A; Allada G; Fennelly KP; Maggiore RJ; Konrad-Martin D
    Int J Audiol; 2018 Sep; 57(sup4):S19-S24. PubMed ID: 28978238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting.
    Harris T; Peer S; Fagan JJ
    J Laryngol Otol; 2012 Jun; 126(6):548-51. PubMed ID: 22459550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center.
    Gambacorta V; Orzan E; Faralli M; Gullà M; Lapenna R; Baietta I; De Angelis V; Ricci G
    Audiol Res; 2023 Oct; 13(5):779-790. PubMed ID: 37887850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of final year medicine, pharmacy, audiology and nursing students in South Africa on drug-induced ototoxicity: A pilot study.
    Mogole O; Schellack N; Hollander C; Ramma L
    S Afr J Commun Disord; 2019 Nov; 66(1):e1-e12. PubMed ID: 31793316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Pursuit of Preventive Audiology in South Africa: Scoping the Context for Ototoxicity Assessment and Management.
    Khoza-Shangase K; Masondo N
    J Pharm Bioallied Sci; 2021; 13(1):46-60. PubMed ID: 34084048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in ototoxicity monitoring in the pediatric oncology population.
    Bass JK; Bhagat SP
    J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of tele-audiology in ototoxicity monitoring: A scoping review.
    Peerbhay N; Munsamy DR; Dlamini HP; Langa F; Paken J
    J Telemed Telecare; 2024 Apr; 30(3):475-496. PubMed ID: 34989631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series.
    Hollander C; Joubert K; Schellack N
    JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14036. PubMed ID: 31934875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making.
    King KA; Brewer CC
    Int J Audiol; 2018 Sep; 57(sup4):S89-S98. PubMed ID: 29276851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing a pharmacotherapy induced ototoxicity programme within a service-learning approach.
    Schellack N; Wium AM; Ehlert K; van Aswegen Y; Gous A
    S Afr J Commun Disord; 2015 Jun; 62(1):E1-7. PubMed ID: 26304216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current state of ototoxicity monitoring in New Zealand.
    Steffens L; Venter K; O'Beirne GA; Kelly-Campbell R; Gibbs D; Bird P
    N Z Med J; 2014 Jul; 127(1398):84-97. PubMed ID: 25146864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current practice of ototoxicity management across the United Kingdom (UK).
    Maru D; Malky GA
    Int J Audiol; 2018 Sep; 57(sup4):S76-S88. PubMed ID: 29676584
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.